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New and Emerging Proteomics Techniques contains
detailed descriptions of modern proteomics techniques
written by experts in the field. The fifteen chapters
describe improved versions or novel combinations of
proteomics methods, including microarrays, two-
dimensional electrophoresis, mass spectrometry, sur-
face plasmon resonance, and bioinformatics, which
enable high throughput, increased sensitivity, or other
advantages over previous versions or an individual
method. Each chapter begins with several pages of
background information and/or an overview of the
method and its uses. The core of each chapter is a
detailed, step-by-step procedure for performing each
technique. Most chapters also include an example of an
experiment using that technique with sample results.
Each chapter concludes with additional detailed notes,
including tips for troubleshooting and ways to avoid
problems, followed by references. A main benefit of the
book is that the procedures and notes are far more
detailed than would be found in most journal articles.
The first few chapters describe novel methods of
microarrays, which enable assaying hundreds or thou-
sands of proteins simultaneously for high-throughput
studies of protein–protein interactions, drug binding, or
enzyme activity or for identifying proteins within a
mixture.
Chapter one details a method to address perhaps the
largest problem in protein microarrays, how to produce
arrays of thousands of proteins without having to
express and purify each protein. With the nucleic acid
programmable protein array (NAPPA) method, the
proteins are expressed through in vitro transcription
and translation in situ from plasmids immobilized on
an array. A plasmid encoded GST tag at the protein’s
C-terminus is used to attach the newly synthesized
protein onto the array via anti-GST antibodies also
immobilized on the array. The method enables prepa-
ration of the many proteins just in time for use, helpingPublished online October 4, 2006
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(J Am Soc Mass Spectrom 2007, 18, 162–164)to decrease problems of protein stability. The chapter
begins by describing issues in constructing protein
arrays and then provides details in preparation of the
DNA, arraying the plasmid and anti-GST antibodies,
and expression of the proteins in situ. Figures provide
an outline of the method and a picture of the proteins
expressed on the array.
Micro-arrays of antibodies provide a powerful
method for detecting many specific proteins in small
amounts of biological fluids or cell extracts, for example
for diagnostic purposes. Chapters 2 and 3 describe
methods for high sensitivity detection of protein anti-
gens bound to antibody arrays. Chapter 2 details use of
rolling circle amplification (RCA). In the example given,
antibodies are first bound to the array, they are used to
retrieve specific antigens from a mixture of proteins,
and a second antibody is used to label the bound
antigen. A DNA primer covalently bound to the second
antibody primes rolling circle amplification of a DNA
circle, and the synthesized DNA is detected by binding
of a fluorescent oligonucleotide. Directions and numer-
ous helpful tips are given for the preparation of the
DNA circles and antibody-primer covalent adducts,
printing of the antibody microarrays, the immunoassay
steps, and the imaging and data analysis.
Chapter 3 describes resonance light-scattering parti-
cles for the staining of biotinylated detection antibodies.
Resonance light-scattering particles are colloidal gold
particles coated with an anti-biotin antibody and can be
observed at high sensitivity by light scattering. Direc-
tions for preparation of the arrays, analysis of antigen
samples, imaging and data analysis, and development
and optimization of a novel array are given in detail.
Figures of the software for interpreting the array are
provided.
Chapter 4 details a method for using chemistry-
based functional proteomics for profiling active en-
zymes, with cellular proteases as an example. The
chapter begins with a good background on the im-
portance of proteases with examples of cellular roles,
variety of activities, and mechanisms of regulation,
which provides a great example of the need for a
method like this to determine which proteins are
active and not just the relative levels of protein
expression in different cell types. The method in-
volves the use of tagged selective and irreversible
inhibitors of the specific proteolytic activities chosen
for study. The protocols cover both the chemical
synthesis and the application of several of these
inhibitors in the study of active proteases in cell
lysates. Labeling of the proteases is followed by
separation of the proteins by 1-D and 2-D electro-
phoresis and Western blotting or autoradiography.
Chapter 5 gives a thorough discussion of the differ-
ence 2-D polyacrylamide gel-based approach to protein
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original proteomics methods, 2-D gels. The difference
method uses a different protein-labeling dye for each
protein mixture being assayed. Then the proteins that
differ between the two samples can be identified and
quantified by analyzing them on a single gel (or multi-
ple gels using the same internal standard), allowing
perfect overlay of the resulting images. The chapter
provides a great introduction including benefits, range,
and limitations of the method, followed by a clear and
detailed protocol. The chapter concludes with exten-
sive, useful notes for sample preparation (including two
tables listing effects of various reagents on dye label-
ing), labeling of samples with dye, removal of contam-
inants such as nucleic acids, range, and limitations. Also
included are some considerations to maximize success
for some specific applications, such as samples that
need detergent or reduction of a sample’s complexity
for identification of less abundant proteins. The author
includes one figure of an example of a scan of a gel with
a Cy3 labeled sample mixed with a Cy5 labeled sample
and also references several papers with additional
examples.
Chapter 6 describes a method of determining the
molecular mass and oligomeric state of proteins by
immediately following fractionation of the sample by
size-exclusion chromatography with analysis using
three detectors in series for measurement of static laser
light scattering (LS), refractive index (RI), and ultravio-
let absorbance (UV). The combined method (SEC-UV/
LS/RI analysis) can be used for native soluble proteins
as well as challenging samples such as glycosylated
proteins, proteins with other posttranslational modifi-
cations, or membrane proteins solubilized in nonionic
detergents (protein detergent complexes), for which
oligomeric state determination is not always possible by
SEC alone. In addition, if the chemical nature of a
carbohydrate, lipid, detergent, or other nonpeptide
moiety is known, the combined approach can be used to
estimate its amount. The introduction provides an ex-
planation of the calculations involved with examples of
results with two well characterized membrane proteins
of known structures, a heptameric hemolysin and a
trimeric maltoporin. The methods, notes, and a table
detail setup and calibration of the instruments, sample
preparation and measurements, selection of the optimal
SEC column, choice of protein standards, and values for
refractive index of the polypeptide chain, and potential
bound moieties. Also included is a step-by-step descrip-
tion of how to use the results for calculating the molar
mass of the polypeptide, oligomeric state, amount of the
nonpolypeptide moiety, and molar mass for the whole
complex.
Chapters 7 and 8 describe methods that involve
surface plasmon resonance (SPR) imaging, which can be
used to study the binding of proteins to other molecules
without the need to label the proteins. Chapter 7 begins
with an explanation of how SPR works followed by
detailed methods for preparation of oligonucleotideand peptide arrays for measuring DNA–protein inter-
actions and peptide–protein interactions, respectively.
Figures illustrating the DNA array fabrication process
and assembly of the SPR sample holder/flow cell are
helpful. Description of the imaging methods is accom-
panied by figures of the results for two DNA binding
proteins (response regulators VanR and OmpR) bind-
ing to an array of cognate and control oligonucleotides
and results for S protein binding to and array of native
and S peptide variants. In Chapter 8, surface plasmon
resonance imaging is combined with mass spectrometry
(SPR-MS), also referred to as biomolecular interaction
analysis mass spectrometry. By combining the two
methods, the same proteins that are retrieved by affinity
to antibodies, oligonucleotides, or peptides on the array
are immediately analyzed further by mass spectrome-
try. The combination enables (1) the identification of
structural features of the interacting proteins, such as
mutations or posttranslational modification via mea-
surement of their masses, (2) assessment of quantitative
variations in protein interactions, and (3) kinetics of
protein interactions. The combination of methods is
illustrated by an example using immobilized antibodies
to capture degraded cardiac troponin I fragments from
a mixture containing human serum proteins. Notes
include helpful information, such as an explanation of
the need for higher chip ligand density in this method
than in usual SPR.
As in Chapter 8, Chapter 9 combines mass spectrom-
etry analysis with a method to enrich a specific protein
target from a mixture. The affinity mass spectrometry
(AMS) described is a high-throughput method that
makes use of microaffinity pipet columns in a parallel
processing robotics workstation. The methods are illus-
trated with isolation and characterization of cystatin C
from human plasma. Methods described include deri-
vatation of affinity pipets (columns) with antibody,
affinity purification of the protein of interest, and MS
analysis. Figures help by illustrating the setup of the
columns andMALDI-target and illustrate the results for
96 human samples, including representative individual
mass spectra for a sample from an average individual
and for samples from individuals with additional trun-
cation variants or a point mutation.
Chapter 10 adds isotope-coded affinity tags (I-CAT)
to affinity chromatography and mass spectrometry for
identifying relative amounts of different proteins in
biological samples. For example, it can be used to look
for changes in the amount of different proteins in
healthy and diseased tissues. The method involves
tagging of cysteine residues in the proteins in the two
biological samples to be compared with two versions of
a tag containing different stable isotopes (that differ by
9 Da). After tagging, the two protein mixtures are
combined and digested with trypsin. The resulting
peptides are subjected to affinity chromatography to
collect the tagged cysteine containing peptides, which
are then analyzed by mass spectrometry. The corre-
sponding proteins are identified through database
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two samples is determined by the heavy:light ratio of
their peptides. The method described is high through-
put, since most proteins contain cysteines, and at the
same time the problem of too much complexity in a
mixture of proteins is solved by looking only at those
peptides that contain cysteine. The description and
protocol are clear with the aid of a flow chart of steps.
Perhaps a sample trace of the results would have been
a nice addition.
Chapter 11 describes multidimensional protein iden-
tification technology (MudPIT) for the separation and
analysis of complex mixtures of peptides from bioflu-
ids, tissues, whole cells, organelles, or protein com-
plexes. It combines biphasic or triphasic microcapillary
columns (containing both reversed-phase and strong
cation exchange resins) in high-performance liquid
chromatography followed by tandem mass spectrome-
try and database searching. The chapter gives good
details about construction of the microcapillary col-
umns, peptide sample preparation, equipment setup,
and suggested gradient profiles for the chromatogra-
phy, with notes on data analysis using SEQUEST or
manually. It also includes tips for dealing with clogged
columns, avoidance of glycerol, and similar useful
notes.
Chapter 12 also describes a method of sample prep-
aration for mass spectrometry. In this case, it is used to
isolate peptides that contain N-linked glycosylation
sites, which is a common and critical posttranslational
modification of many proteins on cell surfaces, secreted
proteins, and proteins in biological fluids. As the au-
thors note, many of the specimens that are accessible for
diagnostic or therapeutic purposes, including proteins
that are biomarkers or drug targets, are glycosylated,
and glycosylation is important for the correct folding,
localization, and function of many of these proteins.
The chapter details attachment of the glycoproteins to
solid support via their N-linked glycan, trypsin diges-
tion of the proteins, removal of the nonglycosylated
peptides, isotopic labeling of the glycopeptides with
stable isotopes (heavy or light succinic anhydride),
release of the glycosylated peptides from the solid
support by digestion by a glycosidase, and then identi-
fication and quantification of the formerly glycosylated
peptides by tandem mass spectrometry and database
searching.
While Chapter 12 details identification of the pep-
tides with N-linked glycosylation, Chapter 13 describes
a novel algorithm, STRucture of OLIGOsaccharides
(StrOligo), for using mass spectrometric data to identify
the composition and possible structures of the glycan.
In the first step, the algorithm identifies the m/z value
between two fragments differing by only one residue
and builds a relationship tree, similar in the methodused in protein sequencing by mass spectrometry. Next,
the algorithm uses the tree to propose possible compo-
sitions of monosaccharides totaling the m/z value of the
glycans studied, to predict the composition of the
glycan. To propose a structure, the algorithm then uses
the tree and composition, along with information from
biosynthetic pathways, to predict possible structures of
the glycan and provide scores as to the match between
the structures and the observed data, which reflects the
fit with the experimental results. Figures of the interface
and samples results are helpful.
Chapter 14 focuses on data analysis for using
spectra from matrix-assisted laser desorption/ioniza-
tion mass spectrometry (MALDI - MS) in biomarker
discovery. The chapter details issues in identifying
significant peaks that differ between disease and
healthy samples, for example collecting of a signifi-
cant number of spectra, calculating appropriate base-
lines, and identifying features in the spectra. An
example is given using 77 control and 93 disease
cases from the National Ovarian Cancer Early Detec-
tion Program.
The final chapter describes analysis of tandem mass
spectra using the global proteome machine (GPM), an
open-source, freely available informatics system for com-
paring spectra with all of the peptide sequences for a
selected organism’s proteome. The system can assist in
identifying proteins, point mutations, posttranslational
modifications, as well as artifact side-chain modifications.
It also connects to a repository of experimental results
from other laboratories for comparison and genomic in-
formation and literature resources. A series of figures and
specific directions help guide the user through the soft-
ware interface. Figures include a list of all results, and the
more detailed results for a single protein, which includes
a sequence coverage map, the amino acid sequence with
indications of exon structure, SNPs, peptide sequences
that have been assigned to spectra, expectation value, and
a protein validation page showing which peptides have
been found by other laboratories for that same protein.
The program also provides a spectrum-to-peptide se-
quence assignment and links to the latest information
about a particular protein from a curated genomic or
cDNA sequence collection. The directions and notes indi-
cate how the user can customize the calculations by
specifying possible side-chain modifications, different
cleavage enzymes, point mutations, species, and similar
information.
Overall, the book’s background information and
detailed protocols and notes would be of interest to
researchers in many areas who are interested in know-
ing more about the types of studies now made possible
by these powerful, combined or individual proteomics
techniques, and how they might be applied to current
questions in basic and medical science.
